Novel imantib resistance mechanisms in chronic myloid leukemia

In my research, I found that the compensatory activation of PI3K/AKT/mTor signaling pathway contributes early imatinib resistance in LAMA cell models. We also found that the auto/paracrine of GM-CSF by imatinib resistant leukemic cells confers to potent imatinib and nilotinib resistance. These findi...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Kaituhi matua: Wang, Ying
Ētahi atu kaituhi: Neubauer, Andreas (Prof. Dr.) (BetreuerIn (Doktorarbeit))
Hōputu: Dissertation
Reo:Ingarihi
I whakaputaina: Philipps-Universität Marburg 2007
Ngā marau:
Urunga tuihono:Kuputuhi katoa PDF
Tags: Tāpirihia he Tūtohu
Keine Tags, Fügen Sie den ersten Tag hinzu!